Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 153473
Author(s) Stoecklin, Georg; Gross, Brigitte; Ming, Xiu-Fen; Moroni, Christoph
Author(s) at UniBasel Moroni, Christoph
Year 2003
Title A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA
Journal Oncogene
Volume 22
Number 23
Pages / Article-Number 3554-61
Keywords ARE, interleukin-3, MRNA decay, tristetraprolin, zinc-finger protein
Abstract The occurrence of pathologically stable mRNAs of proto-oncogenes, growth factors and cyclins has been proposed to contribute to experimental and human oncogenesis. In normal resting cells, mRNAs containing an AU-rich element (ARE) in their 3' untranslated region are subjected to rapid degradation. Tristetraprolin (TTP) is an RNA-binding zinc-finger protein that promotes decay of ARE-containing mRNAs. Here we report that TTP acts as a potent tumor suppressor in a v-H-ras-dependent mast cell tumor model, where tumors express abnormally stable interleukin-3 (IL-3) mRNA as part of an oncogenic autocrine loop. Premalignant v-H-ras cells were transfected with TTP and injected into syngeneic mice. TTP expression delayed tumor progression by 4 weeks, and late appearing tumors escaped suppression by loss of TTP. When transfected into a fully established tumor line, TTP reduced cloning efficiency in vitro and growth of the inoculated cells in vivo. Transgenic TTP interfered with the autocrine loop by enhancing the degradation of IL-3 mRNA with concomitant reduction of IL-3 secretion. Our data establish the ARE as an antioncogenic target in a model situation, underline the importance of mRNA stabilization in oncogenesis and show for the first time that tumor suppression can be achieved by interfering with mRNA turnover.
Publisher Macmillan
ISSN/ISBN 0950-9232
edoc-URL http://edoc.unibas.ch/dok/A5257875
Full Text on edoc No
Digital Object Identifier DOI 10.1038/sj.onc.1206418
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/12789264
ISI-Number WOS:000183399200006
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.518 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
25/04/2024